MYNZ

Mainz Biomed B.V. Ordinary Shares (MYNZ)

About Mainz Biomed B.V. Ordinary Shares (MYNZ)

Mainz Biomed NV is a molecular genetics cancer diagnostic company. The firm is engaged in the developing of market-ready molecular genetic diagnostic solutions for life-threatening conditions. It is involved in the commercializing of its product portfolio in Europe, the United States, and the rest of world. The company was founded on March 08, 2021 and is headquartered in Mainz, Germany.

Details

Daily high

$7.22

Daily low

$5.19

Price at open

$5.24

52 Week High

$49.60

52 Week Low

$3.65

Market cap

13.4M

Dividend yield

0.00%

Volume

672,760

Avg. volume

175,872

P/E ratio

-.10

Mainz Biomed B.V. Ordinary Shares News